Latest Breaking News On - Franchise communications - Page 1 : vimarsana.com

GENFIT: Results from Ipsen s ELATIVE® pivotal Phase III trial of elafibranor in PBC presented as late breaking data at AASLD congress and published in New England Journal of Medicine | 13 11 23

GENFIT: Results from Ipsen s ELATIVE® pivotal Phase III trial of elafibranor in PBC presented as late breaking data at AASLD congress and published in New England Journal of Medicine | 13 11 23
finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.

United kingdomFrance generalUnited statesIpsen euronextIoana piscociuJean christophe marcouxChristelle huguetStephanie boyerAnna gibbinsMo christieChristopher bowlusAmy wolfNicolas boglerGlobal head of franchise communicationsUniversity of california davisHead of patient services

GENFIT: Results from Ipsen s ELATIVE® pivotal Phase III trial of elafibranor in PBC presented as late breaking data at AASLD congress and published in New England Journal of Medicine

GENFIT: Results from Ipsen s ELATIVE® pivotal Phase III trial of elafibranor in PBC presented as late breaking data at AASLD congress and published in New England Journal of Medicine
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomFrance generalUnited statesAmy wolfIpsen euronextAnna gibbinsStephanie boyerIoana piscociuJean christophe marcouxChristopher bowlusChristelle huguetMo christieNicolas boglerUniversity of california davisGlobal head of franchise communicationsUncertainties of the company

Investegate | Company Announcement

Investegate | Company Announcement
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

United statesFrance generalUnited kingdomIpsen euronextIoana piscociuStephanie boyerAmy wolfAnna gibbinsNicolas boglerGlobal head of franchise communicationsHead of corporate brand strategy communicationsExchange commissionUncertainties of the companyNew england journalAmerican associationLiver disease

Newswire & Press Release / US FDA Approves Ipsen s Sohonos™ (palovarotene) Capsules, the First and Only Treatment for People with - Pharma / BioTech / Nutrition - IPSEN Group

Newswire & Press Release / US FDA Approves Ipsen s Sohonos™ (palovarotene) Capsules, the First and Only Treatment for People with - Pharma / BioTech / Nutrition - IPSEN Group
newswiretoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswiretoday.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoFrance generalUnited arab emiratesUnited kingdomMichelle davisIpsen sohonosAnna gibbinsRachel reiffNicolas boglerEdward hsiaoHoward mayerAl mukaddamAmy wolfMineral researchAssociation global registry

US FDA approves Ipsen s SohonosTM (palovarotene) capsules,

Breakthrough treatment reduces new, abnormal bone formation in soft and connective tissues, in people living with ultra-rare bone disease, fibrodysplasia.

France generalUnited arab emiratesSan franciscoUnited statesUnited kingdomEdward hsiaoAmy wolfHoward mayerRachel reiffIpsen euronextAnna gibbinsNicolas boglerAl mukaddamMichelle davisIoana piscociuVal health